Qube Research & Technologies Ltd - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$46,947
-94.8%
10,318
-92.0%
0.00%
-100.0%
Q2 2023$908,843
+51.7%
129,097
+31.7%
0.00%0.0%
Q1 2023$598,969
-49.6%
98,031
-47.3%
0.00%
-50.0%
Q4 2022$1,188,252
+353.5%
185,955
+3190.1%
0.01%
+50.0%
Q4 2020$262,000
-31.2%
5,652
-51.2%
0.00%
-20.0%
Q3 2020$381,000
-76.6%
11,586
-80.5%
0.01%
-79.2%
Q2 2020$1,629,000
+45.2%
59,339
+46.4%
0.02%
-31.4%
Q4 2019$1,122,00040,5220.04%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 3,876,600$127,618,00011.48%
Fairmount Funds Management LLC 596,890$19,650,0008.32%
Ghost Tree Capital, LLC 575,000$18,929,0005.47%
Perceptive Advisors 10,085,632$332,019,0004.85%
Avoro Capital Advisors LLC 9,536,039$313,926,0004.46%
FRAZIER MANAGEMENT LLC 1,312,999$43,224,0003.88%
ACUTA CAPITAL PARTNERS, LLC 315,000$10,370,0002.82%
Orbimed Advisors 6,645,100$218,757,0002.75%
QVT Financial LP 572,971$18,862,0002.30%
Prosight Management, LP 120,606$3,970,0001.89%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders